The clinical manifestations of anti-GAD65 antibody-associated neuroimmune diseases are associated with the distribution of GAD65, with SPS, cerebellar ataxia, or limbic encephalitis as primary manifestations (8). The gene discussed is GAD2; the disease is aceruloplasminemia.